Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 650 for “"TNBC"”.
-
PRUNE_1 INVOLMENT IN TNBC ENHANCING CANCER METABOLISM
… demands. Triple-Negative Breast Cancer (TNBC), characterized by the absence of hormone and HER2 receptors, exhibits high glycolytic and oxidative phosphorylation (OXPHOS) activity, contributing to poor prognosis and metastasis. The ATP5A1 protein, a key component of mitochondrial ATP …
-
The Role Of Cpeb2 Alternative Splicing In TNBC Metastasis
… substantially for triple-negative breast cancer (TNBC) due to its high metastatic potential. Furthermore, there is a lack of targeted therapeutics for TNBC, and clinical trials have been largely unsuccessful. These characteristics validate the need for identifying novel therapeutic targets for the …
-
Heparan Sulfate, A New Target for Platinum in Metastatic TNBC
… Sulfate, A New Target for Platinum in Metastatic TNBC Author: Samantha J. Katner, Ph.D. A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Virginia Commonwealth University, 2018 Advisor: Dr. Nicholas Farrell, Professor, Chemistry Department …
-
Database-driven whole genome profiling for stratifying Triple Negative Breast Cancers (TNBC)
… variants from 88 Triple Negative Breast cancers (TNBCs). Our focus on TNBC was driven by the current and urgent need for better characterization of the genetic, molecular and clinical biomarkers of this heterogeneous, more aggressive and difficult to treat breast cancer subtype for which there are …
-
Investigating Natural Killer Cell-Derived Extracellular Vesicles Using Clinically Relevant TNBC Models
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer with the worst overall survival, yet viable treatment options are limited. The majority of TNBC patients rely on chemotherapy, which has several side effects and limitations. For example, chemotherapy enriches …
-
Τριπλά αρνητικά καρκινώματα του μαστού (TNBC) συσχέτιση με τους ανδρογονικούς υοπδοχείς (AR)
… του μαστού (Triple-negative breast cancer, TNBC) ορίζεται από την απουσία ανιχνεύσιμων υποδοχέων οιστρογόνων (ER), και προγεστερόνης (PR), καθώς και την έλλειψη ενίσχυσης του γονιδίου του υποδοχέα 2 του ανθρώπινου επιδερμικού αυξητικού παράγοντα (HER2). Αυτή η ετερογενής ομάδα αντιπροσωπεύει …
-
Insulin resistance increases TNBC aggressiveness and brain metastasis via adipocyte-derived exosomes
Patients with triple negative breast cancer (TNBC) and comorbid Type 2 Diabetes (T2D), characterized by insulin resistance of adipose tissue, have higher risk of metastasis and shorter survival. Adipocytes are the main non-malignant cells of the breast tumor microenvironment (TME). However, …
-
Polyunsaturated Fatty Acids Alter the Epigenetic Landscape of Triple-Negative Breast Cancer (TNBC)
… of which are triple-negative breast cancer (TNBC) subtypes and have the poorest short-term prognosis. This is probably due to an epithelial to mesenchymal transition (EMT) that tumors undergo, de-differentiating into cancer stem cells. Epigenetic reprogramming is proposed to be required for …
-
Role of IRE1-XBP1 arm in transendothelial migration of TNBC brain metastatic cells
… suffering from Triple Negative Breast Cancer (TNBC) develop brain metastasis which confers poor prognosis to breast cancer patients. However, the mechanisms that facilitate brain metastasis are not fully understood. TNBC cells have high levels of endoplasmic reticulum (ER) stress and show …
-
Development of Rational Combination Therapy With Parp Inhibitors and Kinase Inhibitors In Tnbc
… cancers including triple negative breast cancer (TNBC). However, it has been reported that a subgroup of patients even with BRCA mutation fails to respond to PARPi in multiple clinical trials. In this study, we identified c-Met, a tyrosine kinase, phosphorylates PARP1 at Y907 and that the …
-
Kruppel-like factor 4 (KLF4) regulates protumorigenic signaling in triple-negative breast cancer (TNBC) cells
… axes that endow triple-negative breast cancer (TNBC) cells with enhanced capacity to resist cell stress.;In the first study (Chapter 2), we found that KLF4 promotes the expression of two microRNAs (miRs), miR-206 and miR-21 (miR-206/21), to positively regulate RAS-ERK signaling and dependent …
-
Novel Tyrosine kinase/MEK inhibitor combination impair the viability and invasive potential of TNBC cell lines
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and HER2 expression. TNBC disproportionately affects younger women and is characterized by high rates of recurrence, metastasis, and …
-
Defining the role of PTEN in triple negative breast cancer (TNBC): an experimental and computational approach
… diverse subtypes, triple-negative breast cancer (TNBC) is particularly notorious for its aggressive nature and inferior prognosis compared to other subtypes. Researchers grapple with the significant challenge of developing effective therapies for this malignancy. A contributing factor is the …
-
Inhibition of Hypoxia and EGFR Sensitizes TNBC to Cisplatin and Suppresses Bulk and Cancer Stem Cells
… understanding of triple negative breast cancer (TNBC), the overall survival and disease-free survival for TNBC patients continues to be considerably poorer than their ER/PR/HER2+ counterparts. Metastasis and chemoresistance are the pivotal issues holding back the long-term success of TNBC …
-
Kaiso regulates tumor-suppressing microRNA-31 and microRNA-200c in triple negative breast cancer (TNBC) cells
… with the triple negative breast cancer (TNBC) subtype have a poor prognosis relative to other BC subtypes. As TNBCs do not express the estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor-2 (HER2) that are commonly targeted in hormone positive …
-
The role of DNA damage associated microRNAs in enhancing the chemotherapeutic responses in triple negative breast cancer (TNBC)
Triple negative breast cancer (TNBC) is a heterogeneous aggressive type of mammary tumour which lacks a definite tailored therapeutic approach, consequently limiting treatment options to chemotherapeutic agents. Doxorubicin has demonstrated significant efficacy in the treatment of TNBC although …
-
Lansoprazole and its Metabolites in the Treatment of TNBC and the Contribution of ABCG2 to CC-115 Resistance
Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer with a dismal prognosis. Targeted therapies for breast cancer with expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are currently available; …
-
Receptor tyrosine kinases and circulating tumor cells as new prognostic biomarkers in breast cancer with special focus on TNBC
… from the disease. Triple-negative breast cancer (TNBC) constitutes 7-14% of all breast cancer and is characterized by an aggressive phenotype with poor prognosis and no targeted therapy available. The aim of this thesis was to evaluate new potential prognostic biomarkers in breast cancer, and with …
-
Avaliação do infiltrado linfocítico tumoral (TILs) na doença residual da mama em tumores triplo negativos (TNBC) após a quimioterapia neoadjuvante
… (TILs) no câncer de mama triplo negativo (TNBC) em estágio avançado após a quimioterapia neoadjuvante. Método: Foram analisadas lâminas de tumores triplo-negativos estágios II e III entre os anos de 2008 e 2019 de pacientes com doença residual após QTNA. Os TILs estromais foram analisados …
Page 1 of 33